Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 47597
95 % 2 2 34378 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 1.6
PDBFlex
90 % 2 2 32903
70 % 2 2 29428
50 % 2 2 31532
40 % 2 2 23437
30 % 27 40 1224
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 73498
95 % 1 1 60567
90 % 335 573 4
70 % 1554 2488 2
50 % 3948 6398 1
40 % 3949 6399 1
30 % 3978 6466 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 73497
95 % 1 1 60566
90 % 1 1 57049
70 % 1883 3074 1
50 % 3949 6398 1
40 % 3950 6399 1
30 % 3979 6466 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 73500
95 % 2 2 40864 Flexibility: Low
Max RMSD: 1.1, Avg RMSD: 1.1
PDBFlex
90 % 2 2 30628
70 % 1884 3074 1
50 % 3950 6398 1
40 % 3951 6399 1
30 % 3980 6466 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 47598
95 % 9 10 5769 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 0.9
PDBFlex
90 % 336 573 4
70 % 1555 2488 2
50 % 3951 6398 1
40 % 3952 6399 1
30 % 3981 6466 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 6UCF 1 L N123-VRC34_pI4 light chain 9606
17 6UCF 2 H N123-VRC34_pI4 heavy chain 9606
18 5YD4 1 A, C, E, G scFv 4B08 10090
19 5YD3 1 A, C, E, G scFv 4B08 10090
20 6OC7 1 H Heavy chain of HMP42 Fab 9606
21 6OC7 2 L Light chain for HMP42 Fab 9606
22 5UD9 1 H Fab heavy chain 9606
23 5UD9 2 L Light chain 9606
24 4P48 1 A Antibody scFv 180 9031
25 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
26 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
27 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
28 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
29 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
30 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
31 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
32 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
33 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
34 6MEE 2 B, D antibody HEPC74 Light Chain 9606
35 6BJZ 1 H 5c8 Fab Heavy chain 9606
36 6BJZ 2 L 5c8 Fab Light chain 9606
37 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
38 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
39 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
40 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
41 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
42 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
43 4XCF 1 L 4E10 Fab light chain 9606
44 4XCF 2 H 4E10 Fab heavy chain 9606
45 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
46 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
47 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
48 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
49 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
50 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
51 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
52 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
53 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
54 6UCE 1 L N123-VRC34_pI3 light chain 9606
55 6UCE 2 H N123-VRC34_pI3 heavy chain 9606
56 5X08 1 H Fab 4E10 Heavy chain 9606
57 5X08 2 L Fab 4E10 Light chain 9606
58 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
59 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
60 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
61 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
62 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
63 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
64 6MEG 1 H antibody HEPC46 Heavy Chain 9606
65 6MEG 2 L antibody HEPC46 Light Chain 9606
66 5C2B 1 H scFv 3B4 9606
67 6O3K 1 L PGZL1.H4K3 light chain 9606
68 6O3K 2 H PGZL1.H4K3 heavy chain 9606
69 4XAW 1 L 4E10 Fab light chain 9606
70 4XAW 2 H 4E10 Fab heavy chain 9606
71 4P49 1 A Antibody scFv B8 9031
72 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
73 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
74 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
75 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
76 6TCR 1 H Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
77 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
78 5UCB 1 H Fab Heavy Chain 9606
79 5UCB 2 L Fab Light Chain 9606
80 2VXV 1 H HUMAN IGG ABT-325 9606
81 2VXV 2 L HUMAN IGG ABT-325 9606
82 6QF9 1 A, B scFv 9606
83 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
84 4GXV 1 H, I Antibody 1F1, heavy chain 9606
85 4GXV 2 L, M Antibody 1F1, light chain 9606
86 2VXT 1 H MURINE IGG 125-2H 10090
87 2VXT 3 L MURINE IGG 125-2H 10090
88 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
89 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
90 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
91 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
92 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
93 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
94 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
95 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
96 5W24 1 L 5C4 Fab Light Chain 10090
97 5W24 2 H 5C4 Fab Heavy Chain 10090
98 4HPY 1 H CH59 Fab heavy chain 9606
99 4HPY 2 L CH59 Fab light chain 9606
100 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
101 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
102 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
103 4JG1 1 L Fab light chain 9606
104 4JG1 2 H Fab heavy chain 9606
105 6E65 1 L TB31F Fab light chain 9606
106 6E65 2 H TB31F Fab heavy chain 9606
107 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
108 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
109 5VF2 1 A scFv 2D10 10090
110 5I8C 1 A VRC34.01 Fab heavy chain 9606
111 5I8C 2 B VRC34.01 Fab light chain 9606
112 4O5L 1 L Fab F045-092 light chain 9606
113 4O5L 2 H Fab F045-092 heavy chain 9606
114 5MYX 1 A, C Fab c#24 light chain 10090
115 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
116 3IFL 1 L 12A11 FAB antibody light chain 10090
117 3IFL 2 H 12A11 FAB antibody heavy chain 10090
118 5WK2 1 L M116 LIGHT CHAIN 9606
119 5WK2 2 H M116 HEAVY CHAIN FD 9606
120 3PP4 1 H GA101 Fab heavy chain 10090
121 3PP4 2 L GA101 Fab light chain 10090
122 3KDM 1 A, L Immunoglobulin light chain 9606
123 3KDM 2 B, H Immunoglobulin heavy chain 9606
124 5NIV 1 A Light chain of 5D3 Fab 10090
125 5NIV 2 B Heavy chain of 5D3 Fab 10090
126 6UG7 1 L ch28/11 Fab light chain 10090
127 6UG7 2 H ch28/11 Fab heavy chain 10090
128 5N4J 1 L LIGHT CHAIN 9606
129 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
130 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
131 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
132 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
133 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
134 5X4G 1 A 6H8 Fab heavy chain 10090
135 5X4G 2 B 6H8 Fab light chain 10090
136 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
137 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
138 4PTU 1 A Antibody pn132p2C05, light chain 9606
139 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
140 4TPR 1 L If kappa light chain 10090
141 4TPR 2 H Fab heavy chain 10090
142 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
143 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
144 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
145 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
146 3IFN 1 H 12A11 FAB antibody heavy chain 10090
147 3IFN 2 L 12A11 FAB antibody light chain 10090
148 5U3P 1 H DH511.4 Fab Heavy Chain 9606
149 5U3P 2 L DH511.4 Fab Light Chain 9606
150 6BLA 1 H AMM01 Fab Heavy chain 9606
151 6BLA 2 L AMM01 Fab Light chain 9606
152 4TOY 1 H 35O22 Fab Heavy chain 9606
153 4TOY 2 L 35O22 Fab Light chain 9606
154 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
155 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
156 3NPS 2 B S4 FAB HEAVY CHAIN 9606
157 3NPS 3 C S4 FAB LIGHT CHAIN 9606
158 5I4F 1 A scFv 2D10 10090
159 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
160 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
161 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
162 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
163 5WN9 1 H scFv 2D10 9606
164 4XC3 1 L 4E10 Fab light chain 9606
165 4XC3 2 H 4E10 Fab heavy chain 9606
166 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
167 4M5Y 1 H, I Fab 5J8 heavy chain 9606
168 4M5Y 2 L, M Fab 5J8 light chain 9606
169 4TQE 1 L If kappa light chain 10090
170 4TQE 2 H Fab heavy chain 10090
171 5YY4 1 A scFv 4B08 10090
172 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
173 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
174 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
175 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
176 6Q19 1 L Fab lambda chain 9606
177 6Q19 2 H Fab heavy chain 9606
178 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
179 5VSI 2 L CH1/Ckappa Fab light chain 9606
180 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
181 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
182 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
183 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
184 5JXA 1 H VRC03 Heavy chain 9606
185 5JXA 2 L VRC03 Light chain 9606
186 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
187 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
188 6QCU 1 L Light chain 9606
189 6QCU 2 H Heavy chain 9606
190 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
191 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
192 3NTC 1 L Fab light chain 10090
193 3NTC 2 H Fab heavy chain 10090
194 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
195 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
196 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
197 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
198 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
199 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
200 6PBV 1 A, C Fab668 light chain 9606
201 6PBV 2 B, D Fab668 heavy chain 9606
202 6PZG 1 L NA-80 Fab light chain 9606
203 6PZG 2 H NA-80 Fab heavy chain 9606
204 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
205 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
206 6BE3 1 H Fab (F598) Heavy Chain 9606
207 6BE3 2 L Fab (F598) Light Chain 9606
208 4NWU 1 H APE1551 Ab Fab heavy chain 9606
209 4NWU 2 L APE1551 Ab Fab light chain 9606
210 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
211 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
212 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
213 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
214 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
215 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
216 5EWI 1 H VRC38.01 Heavy Chain 9606
217 5EWI 2 L VRC38.01 Light Chain 9606
218 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
219 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
220 5E2W 1 L AT8 LIGHT CHAIN 10090
221 5E2W 2 H AT8 HEAVY CHAIN 10090
222 5MYK 1 A Fab c#17 light chain 10090
223 5MYK 2 B Fab c#17 heavy chain 10090
224 4NZR 1 H PGT135 heavy chain Fab 9606
225 4NZR 2 L PGT135 light chain Fab 9606
226 5MYO 1 A, C Fab c#6 light chain 10090
227 5MYO 2 B, D Fab c#6 heavy chain 10090
228 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
229 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
230 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
231 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
232 5UEL 1 H 354NC102 Fab Heavy Chain 9606
233 5UEL 2 L 354NC102 Fab Light Chain 9606
234 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
235 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
236 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
237 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
238 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
239 5E2V 1 L AT8 LIGHT CHAIN 10090
240 5E2V 2 H AT8 HEAVY CHAIN 10090
241 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
242 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
243 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
244 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
245 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
246 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
247 5JUE 1 L light chain of UIC2 Fab 10090
248 5JUE 2 H heavy chain of UIC2 Fab 10090
249 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
250 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
251 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
252 5JR1 1 H 10E8 heavy chain 9606
253 5JR1 2 L 10E8 mature light chain 9606
254 6CA7 1 L PCT64_13C light chain 9606
255 6CA7 2 H PCT64_13C heavy chain 9606
256 5VF6 1 A single chain variable fragment 9031
257 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
258 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
259 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
260 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
261 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
262 6MVL 2 H Antibody Fab fragment heavy chain 9606
263 6MVL 3 L Antibody Fab fragment light chain 9606
264 5OB5 2 H fAb Heavy chain 9606
265 5OB5 3 L fAb Light chain 9606
266 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
267 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
268 5I66 1 A 8B6 antibody, heavy chain 10090
269 5I66 2 B 8B6 antibody, light chain 10090
270 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
271 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
272 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
273 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
274 6BZY 1 H 22D11 Heavy Chain 10090
275 6BZY 2 L 22D11 Light Chain 10090
276 3QQ9 1 C, L 101F LIGHT CHAIN 10090
277 3QQ9 2 D, H 101F HEAVY CHAIN 10090
278 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
279 5TKK 3 L mouse antibody vFP5.01 light chain 10090
280 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
281 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
282 5W6C 1 H UCA Fab heavy chain 9606
283 5W6C 2 L UCA Fab light chain 9606
284 5I1K 1 L FAB LIGHT CHAIN 9606
285 5I1K 2 H FAB HEAVY CHAIN 9606
286 3OZ9 1 L Fab NC-1 kappa light chain 10090
287 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
288 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
289 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
290 5V7U 1 L CBTAU-22.1 Fab light chain 9606
291 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
292 5UEA 1 A, H Fab Heavy Chain 9606
293 5UEA 3 B, L Fab Light Chain 9606
294 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
295 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
296 3G5Y 1 A 175 light chain 10090
297 3G5Y 2 B 175 heavy chain 10090
298 5NMV 1 L Fab light chain 10088
299 5NMV 2 H Fab heavy chain 10088
300 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
301 4N8C 2 L, M Light chain of monoclonal antibody 10090
302 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
303 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
304 4HGW 1 A Antibody Fab fragment, light chain 10090
305 4HGW 2 B Antibody Fab fragment, heavy chain 10090
306 1NLB 1 L antibody 19D9D6 light chain 10090
307 1NLB 2 H antibody 19D9D6 heavy chain 10090
308 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
309 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
310 3VFG 1 L 3F8 Light Chain 10090
311 3VFG 2 H 3F8 Heavy Chain 10090
312 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
313 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
314 3QRG 1 L Fab light chain 9606
315 3QRG 2 H Fab heavy chain Fd fragment 9606
316 5M6A 1 A, B, C, D Bence-Jones light chain 9606
317 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
318 4LLY 2 B, D light chain Clambda 9606
319 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
320 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
321 5EZI 1 H Fab c12 heavy chain 9606
322 5EZI 2 L Fab c12 Light chain 9606
323 4K23 1 H anti-uPAR antibody, heavy chain 10090
324 4K23 2 L anti-uPAR antibody, light chain 10090
325 3NCJ 1 L Fab15 Mut8 light chain 9606
326 3NCJ 2 H Fab15 Mut8 heavy chain 9606
327 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
328 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
329 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
330 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
331 5W05 1 L M59 FAB LIGHT CHAIN 10090
332 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
333 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
334 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
335 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
336 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
337 4M61 1 A, C Fab A52 light chain 10090
338 4M61 2 B, D Fab A52 heavy chain 10090
339 5YE3 1 B 2A7D9 VH CH1 chain 10090
340 5YE3 2 A 2A7D9 L chain 10090
341 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
342 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
343 1UM5 1 L Antibody 21H3 L chain 10090
344 1UM5 2 H Antibody 21H3 H chain 10090
345 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
346 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
347 4NWT 1 L APE1531 Ab Fab light chain 9606
348 4NWT 2 H APE1531 Ab Fab heavy chain 9606
349 3WHX 1 A mAb Fab H fragment 10090
350 3WHX 2 B mAb Fab L fragment 10090
351 3NA9 1 L Fab15 light chain 9606
352 3NA9 2 H Fab15 heavy chain 9606
353 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
354 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
355 6RCO 1 A, C R5.004 heavy chain 9606
356 6RCO 2 B, D R5.004 light chain 9606
357 6VBO 1 L DH813 light chain 9606
358 6VBO 2 H DH813 heavy chain 9606
359 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
360 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
361 4LRI 1 A, B MSL-109 Light Chain 9606
362 4LRI 2 C, P MSL-109 Heavy Chain 9606
363 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
364 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
365 4JN2 1 A, L anti dabigatran Fab 10090
366 4JN2 2 B, H anti dabigatran Fab 10090
367 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
368 4XBE 2 H 4E10 Fab heavy chain 9606
369 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
370 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
371 6BE2 1 H Fab (F598) Heavy Chain 9606
372 6BE2 2 L Fab (F598) Light Chain 9606
373 4JFZ 1 L Fab light chain 9606
374 4JFZ 2 H Fab heavy chain 9606
375 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
376 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
377 3WIF 1 A mAb Fab H fragment 10090
378 3WIF 2 B mAb Fab L fragment 10090
379 5U6A 1 A Light Chain 9606
380 5U6A 2 B Heavy Chain 9606
381 6K0Y 1 A Antibody Heavy Chain 9606
382 6K0Y 2 B Antibody Light Chain 9606
383 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
384 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
385 3MBX 1 L X836 LIGHT CHAIN 10090
386 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
387 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
388 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
389 6APC 1 H Epididymis luminal protein 214 9606
390 6APC 2 L IGL@ protein 9606
391 4HHA 1 A Fab KE5 Fab fragment KE5 9606
392 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
393 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
394 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
395 4RGO 2 H 14G8 heavy chain Fab 10090
396 4RGO 3 L 14G8 light chain Fab 10090
397 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
398 5GRY 1 A, G diabody 9606
399 5UEK 2 H Fab 12E Heavy Chain 9606
400 5UEK 3 L Fab 12E Light Chain 9606
401 3NAA 1 L Fab15 Mut5 light chain 9606
402 3NAA 2 H Fab15 Mut5 heavy chain 9606
403 1Q0X 1 L Fab 9B1, light chain 10090
404 1Q0X 2 H Fab 9B1, heavy chain 10090
405 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
406 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
407 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
408 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
409 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
410 5IK3 2 B, D 1E03 Fab fragment light chain 9606
411 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
412 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
413 5XLI 1 a, b FabL 10090
414 5XLI 2 c, d FabH 10090
415 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
416 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
417 6DC4 1 H Fab AM22 Heavy Chain 9606
418 6DC4 2 L Fab AM22 Light Chain 9606
419 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
420 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
421 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
422 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
423 4WUK 1 H CH65 heavy chain 9606
424 4WUK 2 L CH65 light chain 9606
425 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
426 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
427 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
428 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
429 5JOP 1 D, L Fab 14.22 light chain 10090
430 5JOP 2 E, H Fab14.22 heavy chain 10090
431 4HPO 1 H CH58 Fab heavy chain 9606
432 4HPO 2 L CH58 Fab light chain 9606
433 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
434 5UKN 2 L DH522UCA Fab fragment light chain 9544
435 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
436 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
437 5IT2 1 H heavy chain 9606
438 5IT2 2 L light chain 9606
439 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
440 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
441 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
442 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
443 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
444 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
445 5KVE 2 L ZV-48 Antibody scFv 10090
446 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
447 5MO3 3 L Fab of monoclonal antibody, light chain 10090
448 6L8T 1 B, D, L Antibody light chain 9606
449 6L8T 2 A, C, H Antibody heavy chain 9606
450 5GZ0 1 A, C FM329 light chain 1383439
451 5GZ0 2 B, D FM329 heavy chain 1383439
452 6DW2 1 A 6078 Fab light chain 9606
453 6DW2 2 B 6078 Fab heavy chain 9606
454 6MG4 1 A, B JTO light chain 9606
455 6BQB 1 L MGG4 Fab light chain 9606
456 6BQB 2 H MGG4 Fab heavy chain 9606
457 4PUB 1 H DX-2930 HEAVY CHAIN 9606
458 4PUB 2 L DX-2930 LIGHT CHAIN 9606
459 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
460 6B14 2 L Light chain of Fab BL3-6S97N 10090
461 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
462 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
463 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
464 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
465 5GS3 1 A, H diabody protein 9606
466 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
467 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
468 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
469 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
470 5VKD 2 H Fab Heavy Chain 9606
471 5VKD 3 L Fab light chain 9606
472 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
473 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
474 5XHG 1 A, C polypeptide(L) 10090
475 5XHG 2 B, D polypeptide(H) 10090
476 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
477 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
478 3UYR 1 H antibody Fab heavy chain 10090
479 3UYR 2 L antibody Fab light chain 10090
480 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
481 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
482 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
483 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
484 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
485 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
486 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
487 3OAZ 2 K, L Fab 2G12, light chain 9606
488 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
489 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
490 1ZAN 1 L Fab AD11 Light Chain 10116
491 1ZAN 2 H Fab AD11 Heavy Chain 10116
492 6CJK 1 A, C Immunoglobulin Fab light chain 9986
493 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
494 4N0Y 1 H IGH526 Heavy Chain 9606
495 4N0Y 2 L IGH526 Light Chain 9606
496 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
497 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
498 6OTC 2 H sFab H3 heavy chain 32630
499 6OTC 3 L sFab H3 light chain 32630
500 6Q1G 1 L H1244 Fab lambda chain 9606
501 6Q1G 2 H H1244 Fab heavy chain 9606
502 5MTH 1 A, H antibody Fab heavy chain 10090
503 5MTH 2 B, L antibody Fab light chain 10090
504 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
505 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
506 6O26 1 A 3246 Fab heavy chain 9606
507 6O26 2 B 3246 Fab light chain 9606
508 1RZF 1 L Fab E51 light chain 9606
509 1RZF 2 H Fab E51 heavy chain 9606
510 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
511 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
512 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
513 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
514 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
515 4KTE 2 L GE148 Light Chain Fab 9544
516 5I8O 1 H HMM5 antibody heavy chain 9606
517 5I8O 2 L HMM5 antibody light chain 9606
518 4OUO 1 A anti Bla g 1 scFv 9031
519 4JG0 1 L Fab light chain 9606
520 4JG0 2 H Fab heavy chain 9606
521 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
522 4YGV 2 B, L aDabi-Fab2a light chain 9606
523 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
524 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
525 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
526 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
527 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
528 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
529 3EO0 1 A, C GC-1008 Fab Light Chain 10090
530 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
531 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
532 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
533 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
534 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
535 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
536 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
537 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
538 6TCO 2 B, H Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
539 4FQI 3 H antibody CR9114 heavy chain Fab 9606
540 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
541 6S5A 2 H anti P329G LALA Fab heavy chain 10090
542 6S5A 3 L anti P329G LALA Fab light chain 10090
543 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
544 4JHA 2 L D25 light chain 9606
545 6B9Z 1 A Trastuzumab Fab light chain 10090
546 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
547 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
548 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
549 4PTT 1 A Antibody pn132p2C05, light chain 9606
550 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
551 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
552 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
553 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
554 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
555 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
556 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
557 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
558 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
559 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
560 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
561 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
562 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
563 4DGV 1 H HCV1 Heavy Chain Fab 9606
564 4DGV 2 L HCV1 Light Chain 9606
565 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
566 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
567 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
568 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
569 5TH2 1 A, C cetuximab Fab, light chain 10090
570 5TH2 2 B, D cetuximab Fab, heavy chain 10090
571 5I8K 1 L HHH1 Fab Light chain 9606
572 5I8K 2 H HHH1 Fab Heavy chain 9606
573 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
574 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
575 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
576 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
577 1YNL 1 L Ig gamma light chain 10090
578 1YNL 2 H Ig gamma heavy chain 10090
579 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
580 5EPM 2 B, F Antibody Fab fragment light chain 10090
581 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
582 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
583 3UMT 1 A scFv heavy chain and light chain 10090
584 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
585 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
586 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
587 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
588 6UC5 1 H Fab397 heavy chain 9606
589 6UC5 2 L Fab397 light chain 9606
590 4NUJ 1 A PGT152 light chain 9606
591 4NUJ 2 B PGT152 heavy chain 9606
592 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
593 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
594 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
595 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
596 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
597 3U2S 2 B, L PG9 light chain 9606
598 6PE7 1 H FAB Heavy Chain 9606
599 6PE7 2 L FAB Light chain 9606
600 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
601 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
602 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
603 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
604 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
605 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
606 4NUG 1 L PGT151 light chain 9606
607 4NUG 2 H PGT151 heavy chain 9606
608 3IU4 1 H chP3 Fab heavy chain 10090
609 3IU4 2 L chP3 Fab light chain 10090
610 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
611 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
612 6DC8 1 L IgG light chain 10090
613 6DC8 2 H IgG heavy chain 10090
614 6NYQ 1 L 1H3 Fab light chain 10090
615 6NYQ 2 H 1H3 Fab heavy chain 10090
616 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
617 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
618 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
619 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
620 6IAS 1 H Fab NKp46-1 heavy chain 32630
621 6IAS 2 L Fab NKp46-1 light chain 32630
622 1P7K 1 A, L antibody light chain FAB 10090
623 1P7K 2 B, H antibody heavy chain FAB 10090
624 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
625 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
626 3RVV 2 C 4C1 - light chain 10090
627 3RVV 3 D 4C1 - heavy chain 10090
628 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
629 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
630 3P0Y 2 H Fab DL11 heavy chain 9606
631 3P0Y 3 L Fab DL11 light chain 9606
632 4NPY 1 A, L germline PGT121 light chain Fab 9606
633 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
634 6ANA 2 H LL2 Fab Heavy Chain 10090
635 6ANA 3 L LL2 Fab Light Chain 10090
636 5IBU 1 B, L 6652 Light Chain 9606
637 5IBU 2 G, H 6652 Heavy Chain 9606
638 5VPL 2 C 4C1 - LIGHT CHAIN 10090
639 5VPL 3 D 4C1 - HEAVY CHAIN 10090
640 6AOD 1 A FXIa Antibody FAB Light Chain 9606
641 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
642 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
643 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
644 2YPV 2 H FAB 12C1 10090
645 2YPV 3 L FAB 12C1 10090
646 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
647 6TCM 2 H Omalizumab Fab Omalizumab Fab heavy chain 9606
648 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
649 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
650 4JY5 1 L PGT122 light chain Fab 9606
651 4JY5 2 H PGT122 heavy chain Fab 9606
652 6ELE 1 A, H fAB heavy chain 9606
653 6ELE 2 B, L fAB light chain 9606
654 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
655 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
656 6B5R 1 H CIS42 Fab Heavy chain 9606
657 6B5R 2 L CIS42 Fab Light chain 9606
658 3NAC 1 L Fab15 Mut7 light chain 9606
659 3NAC 2 H Fab15 Mut7 heavy chain 9606
660 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
661 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
662 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
663 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
664 1Q72 1 L Fab M82G2, Light chain 10090
665 1Q72 2 H Fab M82G2, Heavy chain 10090
666 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
667 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
668 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
669 6MNQ 3 L Ab DH727.2 light chain 9544
670 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
671 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
672 4YHO 1 H aDabi-Fab3 heavy chain 9606
673 4YHO 2 L aDabi-Fab3 light chain 9606
674 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
675 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
676 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
677 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
678 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
679 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
680 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
681 4DGY 1 H HCV1 Heavy Chain Fab 9606
682 4DGY 2 L HCV1 Light Chain 9606
683 5EN2 1 A GD01 heavy chain 10090
684 5EN2 2 B GD01 light chain 10090
685 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
686 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
687 6P4Y 1 H 4A10 Fab heavy chain 10090
688 6P4Y 2 L 4A10 Fab light chain 10090
689 3MXW 2 L 5E1 light chain 9606
690 3MXW 3 H 5E1 heavy chain 9606
691 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
692 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
693 3EO9 1 L Efalizumab Fab fragment, light chain 9606
694 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
695 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
696 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
697 6N35 1 K, L Fab 2G12 light chain 9606
698 6N35 2 H, M Fab 2G12 heavy chain 9606
699 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
700 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
701 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
702 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
703 5WUV 1 L light chain 9606
704 5WUV 2 H heavy chain 9606
705 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
706 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
707 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
708 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
709 4JM4 1 H PGT 135 Heavy Chain Fab 9606
710 4JM4 2 L PGT 135 Light Chain Fab 9606
711 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
712 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
713 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
714 5YE4 2 B, D 1A9D7 L chain 10090
715 6B0G 1 C 1245 Antibody, Light Chain 9606
716 6B0G 2 D 1245 Antibody, Heavy Chain 9606
717 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
718 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
719 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
720 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
721 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
722 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
723 6D0X 1 A 2140 Antibody, heavy chain 9606
724 6D0X 2 B 1210 Antibody, light chain 9606
725 6BE4 1 H Fab (F598) Heavy Chain 9606
726 6BE4 2 L Fab(F598) Light Chain 9606
727 5TPP 1 L DH270.5 Fab heavy chain 9606
728 5TPP 2 H DH270.5 Fab light chain 9606
729 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
730 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
731 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
732 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
733 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
734 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
735 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
736 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
737 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
738 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
739 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
740 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
741 5TL5 1 L M2177 LIGHT CHAIN 10090
742 5TL5 2 H M2177 HEAVY CHAIN 10090
743 2FX7 1 L Fab 4E10 Light Chain 9606
744 2FX7 2 H Fab 4E10 Heavy Chain 9606
745 6O39 1 A Antibody F2.I Fab, Light chain 9606
746 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
747 5Y9K 1 L belimumab light chain 9606
748 5Y9K 2 H belimumab heavy chain 9606
749 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
750 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
751 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
752 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
753 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
754 6GLW 3 D, L Fab 1D11 - Light chain 9844
755 3WFH 1 A mAb Fab H fragment 10090
756 3WFH 2 B mAb Fab L fragment 10090
757 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
758 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
759 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
760 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
761 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
762 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
763 6GKU 2 H Fab 6F5 - Heavy Chain 9844
764 6GKU 3 L Fab 6F5 - Light chain 9844
765 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
766 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
767 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
768 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
769 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
770 5HI4 3 D, L CAT-2000 FAB light chain 9606
771 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
772 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
773 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
774 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
775 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
776 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
777 3RVW 2 C 4C1 - light chain 10090
778 3RVW 3 D 4C1 - heavy chain 10090
779 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
780 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
781 5XKU 2 B HNIgGA6 light chain 9606
782 5XKU 3 C HNIgGA6 heavy chain 9606
783 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
784 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
785 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
786 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
787 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
788 5HI5 3 D, L CAT-2000 light chain 9606
789 5JO5 1 A, C, E, H 10E8 gHV 9606
790 5JO5 2 B, D, F, L 10E8 gLV 9606
791 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
792 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
793 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
794 5CCK 2 L Antibody 3BC315 Fab light chain 9606
795 6RNN 1 C, L Immunoglobulin light chain 10090
796 6GXX 1 H FAB 1D9 heavy chain 10090
797 6GXX 2 L FAB 1D9 light chain 10090
798 6JP7 1 H immunoglobulin Fab heavy chain 9606
799 6JP7 2 L immunoglobulin Fab light chain 9606
800 5I76 1 A, C FM318_light_chain 1383439
801 5I76 2 B, D FM318_heavy_cahin 1383439
802 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
803 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
804 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
805 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
806 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
807 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
808 5I18 1 L FAB LIGHT CHAIN 9606
809 5I18 2 H FAB HEAVY CHAIN 9606
810 6QB3 2 X scFv55 9606
811 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
812 4JN1 2 L anti-dabigatran Fab1, light chain 10090
813 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
814 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
815 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
816 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
817 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
818 4G5Z 2 L canakinumab antibody fragment light chain 9606
819 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
820 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
821 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
822 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
823 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
824 2OK0 2 L Fab ED10 light chain 10090
825 2OK0 3 H Fab ED10 heavy chain 10090
826 3SOB 1 L antibody light chain 9606
827 3SOB 3 H antibody heavy chain 9606
828 6UG8 1 L ch28/11 Fab light chain 10090
829 6UG8 2 H ch28/11 Fab heavy chain 10090
830 6B5M 1 H CIS43 Fab Heavy chain 9606
831 6B5M 2 L CIS43 Fab Light chain 9606
832 5AWN 1 H Heavy chain of 3BC176 Fab 9606
833 5AWN 2 L Light chain of 3BC176 Fab 9606
834 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
835 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
836 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
837 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
838 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
839 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
840 5DR5 2 L AbD09097 Fab light chain 9606
841 6MG5 1 A, B Light chain JTO 9606
842 2IH3 1 A FAB Heavy Chain 10090
843 2IH3 2 B FAB Light Chain 10090
844 4KQ3 1 L CNTO3186 light chain Fab 9606
845 4KQ3 2 H CNTO3186 heavy chain Fab 9606
846 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
847 6AQ7 3 L POM6 FAB light CHAIN 10090
848 4JFX 1 A, L Fab light chain 9606
849 4JFX 2 B, H Fab heavy chain 9606
850 3SGE 1 I, L Light Chain 10090
851 3SGE 2 H, J Heavy Chain 10090
852 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
853 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
854 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
855 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
856 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
857 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
858 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
859 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
860 5FHB 1 H Antibody 100 Fab heavy chain 9606
861 5FHB 2 L Antibody 100 Fab light chain 9606
862 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
863 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
864 1JGU 1 L Antibody Light Chain 10090
865 1JGU 2 H Antibody Heavy Chain 10090
866 4I77 1 H Lebrikizumab heavy chain Fab 9606
867 4I77 2 L Lebrikizumab light chain Fab 9606
868 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
869 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
870 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
871 4O4Y 2 H 2095-2 heavy chain 9986
872 5OBF 1 H fAb Heavy chain 10090
873 5OBF 2 L fAb Light chain 10090
874 6QNK 1 A, C FAB light chain 10090
875 6QNK 2 B, D FAB heavy chain 10090
876 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
877 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
878 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
879 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
880 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
881 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
882 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
883 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
884 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
885 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
886 5MHE 1 L Fab-fragment 10090
887 5MHE 2 H Fab-fragment 10090
888 5YFI 1 L Light chain of Fab fragment 10090
889 5YFI 2 H Heavy chain of Fab fragment 10090
890 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
891 4GLR 3 I, K anti-ptau light chain light chain 9031
892 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
893 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
894 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
895 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
896 4HJG 1 A Trastuzumab light chain 9606
897 4HJG 2 B Trastuzumab heavy chain 9606
898 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
899 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
900 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
901 5I30 1 L Fab PL-2 light chain 10090
902 5I30 2 H Fab PL-2 heavy chain 10090
903 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
904 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
905 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
906 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
907 6CT7 1 B, L BIIB054 Fab light chain 9606
908 6CT7 2 A, H BIIB054 Fab heavy chain 9606
909 3FN0 1 L Fab Z13e1 light chain 9606
910 3FN0 2 H Fab Z13e1 heavy chain 9606
911 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
912 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
913 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
914 4YHI 2 B, L aDabi-Fab2a light chain 9606
915 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
916 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
917 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
918 5YUP 2